A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma

Blood

Volumn 91, Issue 11, 1998, Pages 4282-4291

  Yakushijin, Yoshihiro ^b   Steckel, Joshua ^b   Kharbanda, Samir ^b   Hasserjian, Robert ^b   Neuberg, Donna ^b   Jiang, Wei Meng ^b   Anderson, Ian ^b   Shipp, Margaret A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL AGGREGATION; EXON; EXPRESSION VECTOR; HUMAN; HUMAN CELL; LIGAND BINDING; METASTASIS POTENTIAL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0032101189     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4282     Document Type: Article

References (51)

1. Jalkanen S, Bargatze R, Herron L, Butcher E: Homing receptors and the control of lymphocyte migration. Immunol Rev 91:39, 1986
2. Stamenkovic I, Amiot M, Pesando J, Seed B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057, 1989
3. Berg E, Goldstein L, Jutila M, Nakache M, Picker L, Streeter P, Wu N, Zhou D, Butcher E: Homing receptors and vascular addressins: Cell adhesion molecules that direct lymphocyte traffic. Immunol Rev 108:5, 1989
4. Aruffo A, Stamenkovic I, Melnick M, Underhill C, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
5. Miyake K, Underhill C, Lesley J, Kincade P: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69, 1990
6. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817, 1992
7. Carter W, Wayner E: Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263:4193, 1988
8. Toyama-Sorimachi N, Sorimachi H, Tobita Y, Kitamura F, Yagita H, Suzuki K, Miyasaka M: A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. J Biol Chem 270: 7437, 1995
9. Weber G, Ashkar S, Glimcher M, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509, 1996
10. Naujokas M, Morin M, Anderson M, Peterson M, Miller J: The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74:257, 1993
11. St John T, Meyer J, Idzerda R, Gallatin W: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60:45, 1990
12. Miyake K, Medina K, Hayashi S, Ono S, Hamaoka T, Kincade P: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171:477, 1990
13. Camp R, Kraus T, Birkeland M, Pure E: High levels of CD44 expression distinguish virgin from antigen-primed B cells. J Exp Med 173:763, 1991
14. Murakami S, Miyake K, Kincade P, Modes R: Functional role of CD44 (Pgp-1) on activated B cells. Immunol Res 10:15, 1991
15. Kincade P, He Q, Ishihara K, Miyake K, Lesley J, Hyman R: CD44 and other cell interaction molecules contributing to B lymphopoiesis. Curr Top Microbiol Immunol 184:215, 1993
16. Kremmidiotis G, Zola H: Changes in CD44 expression during B cell differentiation in the human tonsil. Cell Immunol 161:147, 1995
17. Gallatin W, Weissman I, Butcher E: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30, 1983
18. Jalkanen S, Bargatze R, de los Toyos J, Butcher E: Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-95kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983, 1987
19. Shimizu Y, Van Seventer G, Siraganian R, Wahl L, Shaw S: Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143:2457, 1989
20. Rothman B, Blue M, Kelley K, Wunderlich D, Mierz D, Aune T: Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 147:2493, 1991
21. Galandrini R, Albi N, Tripodi G, Zarcone D, Terenzi A, Moretta A, Grossi C, Velardi A: Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 150:4225, 1993
22. Bourguignon L, Lokeshwar V, Chen X, Kerrick W: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol 151:6634, 1993
23. Entwistle J, Hall C, Turley E: HA receptors: Regulators of signalling to the cytoskeleton. J Cell Biochem 61:569, 1996
24. Taher T, Smit L, Griffioen A, Schilder-Tol E, Borst J, Pals S: Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem 271:2863, 1996
25. Jacobson K, O'Dell D, Holifield B, Murphy T, August J: Redistribution of a major cell surface glycoprotein during cell movement. J Cell Biol 99:1613, 1984
26. Tarone G, Ferracini R, Galetto G, Comoglio P: A cell surface integral membrane glycoprotein of 85,000 mol wt (gp85) associated with Triton X-100-insoluble cell skeleton. J Cell Biol 99:512, 1984
27. Lacy BE, Underhill C: The hyaluronate receptor is associated with actin filaments. J Cell Biol 105:1395, 1987
28. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391, 1994
29. Goldstein L, Zhou D, Picker L, CN M, Bargatze R, Ding J, Butcher E: A human lymphocyte homing receptor, the hernies antigen, is related to cartilage proteolycan core and link proteins. Cell 56:1063, 1989
30. Screaton G, Bell M, Jackson D, Cornelis F, Gerth U, Bell J: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160, 1992
31. Tolg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225, 1993
32. Salles G, Zain M, Boussiotis V, Shipp M: Alternatively spliced CD44 transcripts in diffuse large cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82:3539, 1993
33. Koppman G, Heider K-H, Horst E, Adolf G, van den Berg F, Ponta H, Herrlich P, Pals S: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897, 1993
34. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haubmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
35. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682, 1992
36. Dougherty G, Cooper D, Memory J, Chiu R: Ligand binding specificity of alternatively spliced CD44 isoforms. J Biol Chem 269:9074, 1994
37. Droll A, Dougherty S, Chiu R, Dirks J, McBride W, Cooper D, Dougherty G: Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 270:11567, 1995
38. Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi C, Velardi A: Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 25:2932, 1995
39. van der Voort R, Manten-Horst E, Smit L, Ostermann E, van den Berg F, Pals S: Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem Biophys Res Commun 214:137, 1995
40. Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H: Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 135:1139, 1996
41. Jackson D, Bell J, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673, 1995
42. Sy M, Guo Y-J, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859, 1991
43. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zoller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443, 1993
44. Bennett K, Jackson D, Simon J, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687, 1995
45. Bartolazzi A, Jackson D, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N, Stamenkovic I: Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 108:1723, 1995
46. Moll J, Schmidt A, van der Putten H, Plug R, Ponta H, Herrlich P, Zoller M: Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. J Immunol 156:2085, 1996
47. Stauder R, Eisterer W, Thaler J, Gunthert U: CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood 85:2885, 1995
48. Picker L, Medeiros L, Weiss, LM, Warnke, RA, Butcher E: Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma. Am J Pathol 130:496, 1988
49. Pals S, Horst E, Ossekoppele G, Figdor C, Scheper R, Meijer C: Expression of lymphocyte homing receptor as a mechanism of dissemination in NHL. Blood 72:885, 1989
50. Jalkanen S, Joensuu H, Klemi P: Prognostic value of lymphocyte homing receptor and S Phase fraction in non-Hodgkin's lymphoma. Blood 75:1549, 1990
51. Horst E, Meijer C, Radaszkiewicz T, Ossekoppele G, van Krieken J, Pals S: Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44). LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595, 1990